Der Schmerz

, Volume 25, Issue 1, pp 26–44 | Cite as

Epidemiologie von nicht tumorbedingten chronischen Schmerzen in Deutschland

Übersichten

Zusammenfassung

Hintergrund

Obwohl verbreitet, liegen Angaben zu epidemiologischen Aspekten chronischer Schmerzen nur eingeschränkt vor. Ziel der Arbeit ist es, Informationen zu nicht tumorbedingten chronischen Schmerzen in Deutschland darzustellen.

Methoden

Sieben Datenbanken (1995–2009) und weitere Quellen wurden durchsucht, um relevante Arbeiten zu chronischen Schmerzen (>3 Monate) zu finden. Die Auswahl erfolgte nach Aktualität, Größe, Repräsentativität und Qualität.

Ergebnisse

Die Prävalenz chronischer Schmerz in Deutschland beträgt rund 17% und variiert je nach Ursache. Besonders häufig sind Nacken-, Schulter- und Rückenschmerzen.

Chronische Schmerzen haben einen direkten Einfluss auf Lebensqualität (LQ), Krankheitstage und -kosten.

Viele medikamentöse und nichtmedikamentöse Therapien werden eingesetzt. Die Behandlung ist oft nicht adäquat, 13–51% der Patienten erhalten eine ungenügende Schmerztherapie.

Schlussfolgerung

Chronische Schmerzen sind ein häufiges Problem. Sie nehmen Einfluss auf die LQ der Patienten und verursachen nicht unerhebliche Behandlungskosten. Die Therapie erfolgt oft nicht adäquat. Mehr Forschung ist erforderlich, um vorhandene Wissenslücken zu schließen. Der Transfer von Forschungsergebnissen in die Praxis sollte verstärkt werden.

Schlüsselwörter

Schmerz Chronische Erkrankung Epidemiologie Prävalenz Inzidenz 

Abkürzungsverzeichnis

ANOVA

„analysis of variance”

BIP

Bruttoinlandsprodukt

BMI

Body-Mass-Index

CDSR

Cochrane Database of Systematic Reviews

CENTRAL

Cochrane Central Register of Controlled Trials

CRD

Centre for Reviews and Dissemination

CS

Chronifizierungsstadium

DARE

Database of Abstracts of Reviews of Effects

DT

Duncan-Test

EMBASE

Excerpta Medica Database

EU NHWS

EU National Health and Wellness Survey

GBPRN

German Back Pain Research Network

GEK

Gmünder Ersatzkasse

GIN

Guidelines International Network

HTA

Health Technology Assessment

ICD

International Statistical Classification of Diseases and Related Health Problems

IMS

Intercontinental Marketing Services

KI

Konfidenzintervall

LFESSQ

London Fibromyalgia Epidemiology Study Screening Questionnaire

m

männlich

MEDLINE

Medical Literature Analysis and Retrieval System Online

min

Minute

MNSI

Michigan Neuropathic Screening Instrument

MPSS

Mainz Pain Staging System

MW

Mittelwert

n

Anzahl

NRS

numerische Ratingskala

Ovid

Ovid Technologies, Inc.

p

„probability“ (Wahrscheinlichkeit)

RKI

Robert-Koch-Institut

S.

Schmerz(en)

SD

„standard deviation“ (Standardabweichung)

SE

„standard error“ (Standardfehler)

SF

Short Form Health Survey

TENS

transkutane elektrische Nervenstimulation

VA

ANOVA (s.o.)

VAS

visuelle Analogskala

w

weiblich

WHO

World Health Organisation (Weltgesundheitsorganisation)

Epidemiology of chronic non-malignant pain in Germany

Abstract

Background

Although chronic pain is a common health problem, epidemiological data are rare. The aim of this study is to present information on chronic, non-malignant pain in Germany.

Methods

In order to identify relevant studies on chronic pain (>3 months) a total of 7 databases were searched in the timeframe from 1995 to 2009. Representative, recent, comprehensive and valid studies were selected.

Results

The prevalence of chronic pain in Germany is estimated to be 17% and varies according to the underlying cause of the disease. Neck, shoulder and back pain are the most common forms. Chronic pain has a direct impact on quality of life (QoL), days off work and costs. A variety of drugs and non-drug treatments are used. However, treatment is often inadequate with 13–51% of the patients receiving insufficient pain therapy.

Conclusions

Chronic pain is a common problem which influences the QoL of patients resulting in high costs for the health system. Treatment is often inadequate. More research is needed to close knowledge gaps. The transfer of research results into clinical practice should be improved.

Keywords

Pain Chronic disease Epidemiology Prevalence Incidence 

Notes

Interessenkonflikt

Der korrespondierende Autor weist auf folgende Beziehung hin: Die vorliegende Arbeit wurde durch die Grünenthal GmbH in Auftrag gegeben und finanziert. Grünenthal wurde die Möglichkeit gegeben, den Entwurf dieser Arbeit zu kommentieren, wobei die Autoren volle Freiheiten bezüglich Inhalt und Ausgestaltung der Publikation hatten.

Literatur

  1. 1.
    Breivik H, Collett B, Ventafridda V et al (2006) Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 10(4):287–333CrossRefPubMedGoogle Scholar
  2. 2.
    NICE (2008) Do Once and Share: Pain Assessment. URL: http://www.library.nhs.uk/palliativeSearchResults.aspx?tabID=289&optID=66&pgIndex=1&. National Institute for Health and clinical Excellence. http://www.library.nhs.uk/palliativeViewResource.aspx?resID=280345&tabID=289 (letzter Zugriff 20.09.2008)Google Scholar
  3. 3.
    von Altmann EE, Egger DG, Pocock M et al (2008) The Strengthening of the Reporting of Observational Studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61(4):344–349CrossRefGoogle Scholar
  4. 4.
    Centre for Reviews and Dissemination (2008) Systematic Reviews. CRD’s guidance for undertaking reviews in health care. Centre for Reviews and Dissemination, University of YorkGoogle Scholar
  5. 5.
    Bellach B-M, Ellert U, Radoschewski M (2000) Epidemiologie des Schmerzes – Ergebnisse des Bundes-Gesundheitssurveys 1998. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 43:424–431CrossRefGoogle Scholar
  6. 6.
    Berger A, Toelle T, Sadosky A et al (2009) Clinical and economic characteristics of patients with painful neuropathic disorders in Germany. Pain Pract 9(1):8–17CrossRefPubMedGoogle Scholar
  7. 7.
    Beutel ME, Weidner W, Brahler E (2004) Chronic pelvic pain and its comorbidity. Urologe A 43(3):261–267CrossRefPubMedGoogle Scholar
  8. 8.
    Branco JC, Bannwarth B, Failde I et al (2010) Prevalence of fibromyalgia: A survey in five European countries. Semin Arthritis Rheum 39:448–453CrossRefPubMedGoogle Scholar
  9. 9.
    Chrubasik S, Junck H, Zappe HA, Stutzke O (1998) A survey on pain complaints and health care utilization in a German population sample. Eur J Anaesthesiol 15(4):397–408PubMedGoogle Scholar
  10. 10.
    Freynhagen R, Baron R, Tolle T et al (2006) Screening of neuropathic pain components in patients with chronic back pain associated with nerve root compression: a prospective observational pilot study (MIPORT). Curr Med Res Opin 22(3):529–537CrossRefPubMedGoogle Scholar
  11. 11.
    Hauser W, Schmutzer G, Glaesmer H, Brahler E (2009) Prevalence and predictors of pain in several body regions. Results of a representative German population survey. Schmerz 23(5):461–470CrossRefPubMedGoogle Scholar
  12. 12.
    Heidemann C, Kroll L, Icks A et al (2009) Prevalence of known diabetes in German adults aged 25–69 years: results from national health surveys over 15 years. Diabet Med 26(6):655–658CrossRefPubMedGoogle Scholar
  13. 13.
    Kern U, Busch V, Rockland M et al (2009) Prevalence and risk factors of phantom limb pain and phantom limb sensations in Germany. A nationwide field survey. Schmerz 23(5):479–488CrossRefPubMedGoogle Scholar
  14. 14.
    Kohler M, Ziese T (2004) Telefonischer Gesundheitssurvey des Robert Koch-Instituts zu chronischen Krankheiten und ihren Bedingungen. Robert Koch-Institut, BerlinGoogle Scholar
  15. 15.
    Komarahadi F, Baumeister H, Maurischat C, Harter M (2006) Distribution of pain parameters for chronic pain patients in comparison to the general population. Schmerz 20(2):108–118CrossRefPubMedGoogle Scholar
  16. 16.
    Neuhauser H, Ellert U, Ziese T (2005) Chronic back pain in the general population in Germany 2002/2003: prevalence and highly affected population groups. Gesundheitswesen 67(10):685–693CrossRefPubMedGoogle Scholar
  17. 17.
    Nickel R, Egle UT, Schwab R (2002) Diagnostic subgroups and psychosocial characteristics in chronic non-malignant pain patients referred to an out-patient pain center. Psychother Psychosom Med Psychol 52(9–10):378–385Google Scholar
  18. 18.
    Raspe A, Matthis C, Heon-Klin V, Raspe H (2003) Chronic back pain: more than pain in the back. Findings of a regional survey among insurees of a workers pension insurance fund. Rehabilitation 42(4):195–203CrossRefPubMedGoogle Scholar
  19. 19.
    Schneider S, Schmitt G, Mau H et al (2005) Prevalence and correlates of osteoarthritis in the FRG. Orthopäde 34:782–790CrossRefPubMedGoogle Scholar
  20. 20.
    Schneider S, Schmitt G, Richter W (2006) Prevalence and correlates of inflammatory arthritis in Germany: data from the first national health survey. Rheumatol Int 27(1):29–38CrossRefPubMedGoogle Scholar
  21. 21.
    Thiem U, Schumacher J, Zacher J et al (2008) Prevalence of musculoskeletal complaints and self-reported joint osteoarthritis in the population of Herne: a telephone survey. Z Rheumatol 67(5):432–439PubMedGoogle Scholar
  22. 22.
    Ziegler D, Rathmann W, Dickhaus T et al (2009) Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: The MONICA/KORA Augsburg surveys S2 and S3. Pain Med 10(2):393–400CrossRefPubMedGoogle Scholar
  23. 23.
    Consumer Health Sciences (2009) The Pain Market: EU Big 5 Core Therapeutic Report; National Health and Wellness Survey 2008. Princeton, NJGoogle Scholar
  24. 24.
    Bauknecht M, Braun B, Müller R (2009) GEK-Bandscheiben-Report – Vorsorgungsforschung mit GEK-Routinedaten. Schwäbisch GmündGoogle Scholar
  25. 25.
    Latza U, Pfahlberg A, Gefeller O (2002) Impact of repetitive manual materials handling and psychosocial work factors on the future prevalence of chronic low-back pain among construction workers. Scand J Work Environ Health 28(5):314–323PubMedGoogle Scholar
  26. 26.
    Neubauer E, Pirron P, Junge A et al (2005) What questions are appropriate for predicting the risk of chronic disease in patients suffering from acute low back pain?. Z Orthop Ihre Grenzgeb 143(3):299–301CrossRefPubMedGoogle Scholar
  27. 27.
    Meister W, Neiss A, Gross G et al (1998) Demography, symptomatology, and course of disease in ambulatory zoster patients. A physician-based survey in Germany. Intervirology 41(6):272–277CrossRefPubMedGoogle Scholar
  28. 28.
    Becker A, Seitz R, Jacobi E, Leidl R (2001) Cost evaluation by a patient questionnaire: pilot study of a weekly cost diary. Rehabilitation 40(1):12–20CrossRefPubMedGoogle Scholar
  29. 29.
    Bolten W, Kempel-Waibel A, Pforringer W (1998) Analysis of the cost of illness in backache. Med Klin 93(6):388–393CrossRefGoogle Scholar
  30. 30.
    Frettloh J, Maier C, Gockel H, Huppe M (2003) Validation of the German Mainz pain staging system in different pain syndromes. Schmerz 17(4):240–251CrossRefPubMedGoogle Scholar
  31. 31.
    Gerbershagen HU, Lindena G, Korb J, Kramer S (2002) Health-related quality of life in patients with chronic pain. Schmerz 16(4):271–284CrossRefPubMedGoogle Scholar
  32. 32.
    Grobe TG, Dörning H, Schwartz FW (2010) Barmer GEK Arztreport. Report No.: Band 1Google Scholar
  33. 33.
    Hampel P, Moergel MF (2009) Staging of pain in patients with chronic low back pain in inpatient rehabilitation: Validity of the Mainz pain staging system of pain chronification. Schmerz 23(2):154–165CrossRefPubMedGoogle Scholar
  34. 34.
    Michalski D, Hinz A (2006) Severity of chronic back pain: Assessment with the Mainz pain staging system. Schmerz 20:198–209CrossRefPubMedGoogle Scholar
  35. 35.
    Pfingsten M, Schops P, Wille T et al (2000) Classification of chronic pain. Quantification and grading with the Mainz pain staging system. Schmerz 14(1):10–17CrossRefPubMedGoogle Scholar
  36. 36.
    Schmidt CO, Schweikert B, Wenig CM et al (2009) Modelling the prevalence and cost of back pain with neuropathic components in the general population. Eur J Pain 13(10):1030–1035CrossRefPubMedGoogle Scholar
  37. 37.
    Wenig CM, Schmidt CO, Kohlmann T, Schweikert B (2009) Costs of back pain in Germany. Eur J Pain 13(3):280–286CrossRefPubMedGoogle Scholar
  38. 38.
    Schulte E, Hermann K, Berghofer A et al (2010) Referral practices in patients suffering from non-malignant chronic pain. Eur J Pain 14(3):308–308CrossRefPubMedGoogle Scholar
  39. 39.
    Basler HD, Hesselbarth S, Kaluza G et al (2003) Comorbidity, multiple medication, and well-being in elderly patients with chronic pain. Schmerz 17(4):252–260CrossRefPubMedGoogle Scholar
  40. 40.
    Frießem CH, Willweber-Strumpf A, Zenz MW (2009) Chronic pain in primary care. German figures from 1991 and 2006. BMC Public Health 9:299CrossRefPubMedGoogle Scholar
  41. 41.
    Becker A, Breyer R, Kolling W et al (2007) Low back pain in practice: What do general practitioners do and what orthopaedists? Z Allgemeinmed 83(2):44–50CrossRefGoogle Scholar
  42. 42.
    Lang E, Eisele R, Bickel A et al (1999) Structure quality in outpatient care of chronic pain patients. Schmerz 13(2):102–112CrossRefPubMedGoogle Scholar
  43. 43.
    Renker EK, Schluter J, Neubauer E, Schiltenwolf M (2009) Therapy of patients with chronic back pain. Prescriptions-contentment-outcome. Schmerz 23(3):284–291PubMedGoogle Scholar
  44. 44.
    Lang E, Katalinic A, Sittl R et al (1997) Outpatient management of chronic pain in Middle Franconia. Schmerz 11(2):101–107CrossRefPubMedGoogle Scholar
  45. 45.
    Maier C, Schaub C, Willweber-Strumpf A, Zenz M (2005) Long-term efficiency of opioid medication in patients with chronic non-cancer-associated pain. Results of a survey 5 years after onset of medical treatment. Schmerz 19:410–417CrossRefPubMedGoogle Scholar
  46. 46.
    Junker U, Sarnow E, Leverkus F (2008) Treatment of patients with chronic pain due to degenerative or inflammatory joint disorders with tilidine/naloxone sustained release tablets after insufficient analgesic pretreatment. Med Welt 59(1–2):42Google Scholar
  47. 47.
    Häuser W, Grulke N, Michalski D et al (2009) Intensity of limb pain and fatigue in fibromyalgia syndrome, depressive disorders and chronic back pain. A criterion for differentiation. Schmerz 23(3):267–274CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  1. 1.Kleijnen Systematic Reviews LtdYorkUK
  2. 2.Researcher in Systematic ReviewsBerlinDeutschland
  3. 3.Researcher in Systematic ReviewsHannoverDeutschland
  4. 4.Care and Public Health Research Institute (CAPHRI)Universität MaastrichtMaastrichtNiederlande

Personalised recommendations